Tristel (TSTL)

Sector:

Health Care

Index:

FTSE AIM 100

405.00p
   
  • Change Today:
    -2.50p
  • 52 Week High: 440.00
  • 52 Week Low: 355.00
  • Currency: UK Pounds
  • Shares Issued: 48.07m
  • Volume: 32,962
  • Market Cap: £194.70m
  • RiskGrade: 180
  • Beta: 0.01

Tristel Overview

We are an infection prevention company. The entire purpose of our business is to prevent the transmission of microbes from one object or person to another. We achieve our mission by applying a very powerful biocidal chemistry – chlorine dioxide – to the target environmental surface or medical device. We are one of a very few companies worldwide that can legitimately claim to be exclusively an infection prevention business.
Competitors: Trellus Health, Open Orphan , Mediclinic International , Cambridge Cognition Holdings, Sourcebio International, Sensyne Health, CareTech Holding, Diaceutics

Key Personnel

CEO: Christopher ( Lee
CFO: Anna Wasyl
Independent Non-Executive Director: Caroline Stephens
Non-Executive Chairman: Bruno Holthof
Senior Independent Director: Isabel J S Napper
Non-Executive Dir: Tom Jenkins

Contact Details

Address: Unit 1B Lynx Business Park, Fordham Road, Snailwell, Newmarket, Cambridgeshire , United Kingdom, CB8 7NY
Phone: 44 (0) 1638 721500
Fax: 44 (0) 1638 721911
Website: http://www.tristel.com

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share, FTSE AIM 100
ISIN: GB00B07RVT99

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Tristel Market Data

Currency UK Pounds
Share Price 405.00p
Change Today -2.50p
% Change -0.61 %
52 Week High 440.00
52 Week Low 355.00
Volume 32,962
Shares Issued 48.07m
Market Cap £194.70m
Beta 0.01
RiskGrade 180

Tristel Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
91% below the market average91% below the market average91% below the market average91% below the market average91% below the market average
76% below the sector average76% below the sector average76% below the sector average76% below the sector average76% below the sector average
Price Trend
11.08% above the market average11.08% above the market average11.08% above the market average11.08% above the market average11.08% above the market average
58.62% above the sector average58.62% above the sector average58.62% above the sector average58.62% above the sector average58.62% above the sector average
Income
20.66% above the market average20.66% above the market average20.66% above the market average20.66% above the market average20.66% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
63.16% above the market average63.16% above the market average63.16% above the market average63.16% above the market average63.16% above the market average
35.71% below the sector average35.71% below the sector average35.71% below the sector average35.71% below the sector average35.71% below the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 2
Sell 0
Strong Sell 0
Total 5
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Tristel Dividends

  Latest Previous
  Final Interim
Ex-Div 26-Nov-26 19-Mar-26
Paid 17-Dec-26 09-Apr-26
Amount 9.23p 5.68p

Trades for 28-Oct-2026

Time Volume / Share Price
16:23 2,300 @ 400.00p
16:09 5,490 @ 405.75p
15:25 3,014 @ 401.00p
15:21 4 @ 406.25p
15:20 891 @ 401.20p

Tristel Key Personnel

CFO Anna Wasyl
CEO Christopher ( Lee

Top of Page